CSL dans l'actualité
Médicaments et vaccins biotechnologiques
Tamtam a trouvé 13 articles récents sur CSL.
- CSL shares: Buy, hold, or sell?
- Will CSL's Alentis Deal Reset Its Kidney Strategy (ASX:CSL)?
- CSL Limited (ASX:CSL): FY2026 Earnings Reflect Impairments and Biopharmaceutical Operations
- CSL vaccines unit slammed over UK compliance failures
- CSL vs CBA: Which ASX share is best for SMSFs?
- CSL to drop Terumo for Haemonetics in US plasma collection supply deal
- CSL Seqirus blasted for ‘multiple and prolonged deficiencies’
- Haemonetics shares jump as CSL sets 2027 rollout of plasma devices
- CSL (ASX:CSL) Backs Lixudebart As Investors Ask If The Undervalued View Still Holds
- CSL announces investment for share of Alentis rare kidney and liver candidate
- CSL Strikes New Deal as Shares Enjoy Rare Period Of Consolidation
- Australian Shares Flat; CSL Partners With Alentis Therapeutics to Develop Rare Kidney, Liver Disease Drug
- CSL signs deal with Trump administration to slash prices for its medicines
Articles collectés par Tamtam et retenus lorsqu'ils portent sur l'entreprise, des plus récents aux plus anciens. Chacun renvoie à sa source.
Vous vendez à des entreprises comme CSL ?
Tamtam trouve les entreprises qui correspondent à votre client idéal, analyse chaque compte et vous dit qui contacter, et quand.
Trouver des entreprises similaires